After 24 weeks of iptacopan monotherapy, mean C3 deposition on red blood cells had decreased to <1% in eculizumab-experienced patients with PNH, and C3 deposition did not occur in patients who were eculizumab-naive [87]. Here, C3 is linked to paroxysmal nocturnal hemoglobinuria.